Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Develogen AG
company
About
A biology-driven drug discovery company developing novel therapies for diabetes and obesity
- 11 - 50
Highlights
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- €40M
- Industries
- Biotechnology,Health Care,Medical,Therapeutics
- Founded date
- Jan 1, 1997
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Develogen is a biology-driven drug discovery company that is engaged in the development of therapies for diabetes and obesity. The company was founded in 1995 and is based in Georgia, United States.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
€40M
Develogen AG has raised a total of
€40M
in funding over 2 rounds. Their latest funding was raised on
Apr 18, 2001 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Apr 18, 2001 | Series B | €40M | 1 |
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Develogen AG is funded by 1 investors.
Dresdner Kleinwort Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
Yes | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
